UTMB Clinical and Translational Science Award
UTMB 临床和转化科学奖
基本信息
- 批准号:9085702
- 负责人:
- 金额:$ 32.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-18 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:Academic TrainingAddressAwardBasic ScienceBehavior TherapyClinicalClinical ResearchClinical SciencesClinical TrialsCommunicationDevelopmentDevicesDiagnosticDisciplineDiseaseDoctor of PhilosophyEducational CurriculumEnrollmentEntrepreneurshipEthical IssuesFacultyFellowshipFundingFutureGoalsHealthHumanHuman Subject ResearchHybridsIndustryInterventionKnowledgeLaboratoriesLeadershipLettersMediationMedical StudentsMentorsMethodsModelingPharmaceutical PreparationsPositioning AttributePostdoctoral FellowProgram EvaluationRecruitment ActivityResearchResearch ActivityResearch DesignResearch InfrastructureResearch Project GrantsResearch TrainingResourcesRotationSchoolsScienceStudentsTestingTherapeuticTrainingTraining ProgramsTraining SupportTranslational ResearchUnderrepresented MinorityWorkbaseconflict resolutiongraduate studentimprovedinnovationmeetingsmultidisciplinarypre-doctoralprogramsscience educationskillssuccesstool
项目摘要
ABSTRACT
This TL1 Training Core, in support of the UTMB CTSA U54 application, will provide “predoctoral students (3
trainees/year) with a deep orientation to translational science, and postdoctoral fellows (3 scholars/year) with
advanced research training aligned with the CTSA's goals of advancing therapeutics (drugs, devices,
diagnostics and preventatives), clinical interventions, and behavioral modifications to improve human health.”
Existing curricula and training programs at UTMB, as elsewhere, excel at developing discipline-specific
knowledge and technical skills, but are less effective at developing the core skills and competencies essential
for the effective and efficient practice of team-based translational science; these are: team management,
shared leadership, conflict resolution and negotiations, interprofessional communication, entrepreneurship, and
the regulatory and ethical issues associated with human subjects research and clinical trials. To address this
gap, we will build on our CTSA hub's successful application of a hybrid industry “work team”-academic
approach to translational research using a Multidisciplinary Translational Team (MTT) model. We will also use
a training model that is based on our successful implementation of a competency-driven curriculum for a new
translational PhD program. We will recruit from a sufficiently large pool of trainees in any of our 13 biomedical
graduate programs, including a large proportion of underrepresented minorities, which is mirrored by a diverse
faculty. Of key importance, the GSBS and the UTMB Provost initiated and fund financial supplements for
students recruited as Presidential Scholars to encourage the enrollment of outstanding graduate students.
Potential trainees will be advised to pursue laboratory rotations with MTT-based faculty. Once a mentoring
team is selected, students and their mentors will apply for training positions (predoctoral fellowship) in the TL1
Training Core. Postdoctoral scholars will be specifically recruited to the program by MTT-based mentors
(Program Faculty). Among others, three particularly innovative components of the required curriculum include:
1) the Interprofessional Translational Research Design Course, which includes medical students and PhD
students working in teams; 2) the Clinical Encounters Program, which addresses the need for trainees and
scholars to be educated in the human health- and disease-related aspects of their research; and 3)
dissertation/postdoctoral research projects co-mentored by both scientific and clinical experts. Lastly, our
training program's evaluations will use relevant, validated assessment tools such as the Teamwork
Competency Test and others. Primary financial resources, space, and staff are committed by UTMB to provide
oversight, key core resources, integrative programs and seminars for this Training Core. The Graduate School
of Basic Sciences also provides financial and infrastructure support for the Training Core. Lastly, the
supporting letter from the UTMB Provost enumerates the current and future commitments to the ITS, which
assure the success of this oversight entity for our innovative training program.
摘要
这个TL1培训核心,支持UTMB CTSA U54申请,将提供“博士前学生(3
实习生/年),深入研究翻译科学;博士后研究员(3名学者/年)
高级研究培训与CTSA推进治疗学(药物、设备、
诊断和预防)、临床干预和行为改变,以改善人类健康。
与其他地方一样,UTMB现有的课程和培训计划擅长制定特定学科的课程和培训计划
知识和技术技能,但在发展必要的核心技能和能力方面效率较低
以团队为基础的翻译科学的有效和高效实践;这些是:团队管理,
共享领导力、冲突解决和谈判、跨专业交流、企业家精神和
与人类受试者研究和临床试验相关的监管和伦理问题。要解决这个问题
GAP,我们将建立在我们的CTSA中心成功应用混合行业“工作组”的基础上--学术
采用多学科翻译团队(MTT)模式进行翻译研究。我们还将使用
基于我们成功实施能力驱动的新课程的培训模式
翻译博士项目。我们将从足够多的受训人员中招募13个生物医学专业中的任何一个
研究生课程,包括很大比例的代表不足的少数族裔,这与多样化的
教职员工。最重要的是,GSBS和UTMB教务长发起并资助了
招募学生为总统学者,鼓励优秀研究生入学。
潜在的受训者将被建议与以四甲基偶氮唑蓝为基础的教员进行实验室轮换。曾经是一名导师
团队被选中,学生和他们的导师将申请TL1中的培训职位(博士前奖学金)
培训核心。博士后学者将由基于MTT的导师专门招募到该项目中
(计划学院)。除其他外,必修课程的三个特别创新的组成部分包括:
1)跨专业翻译研究设计课程,包括医学生和博士生
学生以小组形式工作;2)临床接触计划,该计划解决了对受训人员和
对学者进行与人类健康和疾病相关的研究方面的教育;以及
由科学和临床专家共同指导的论文/博士后研究项目。最后,我们的
培训计划的评估将使用相关的、经过验证的评估工具,如团队合作
能力测试和其他。UTMB承诺提供主要的财政资源、空间和人员
监督,关键核心资源,综合计划和研讨会,为该培训核心。研究生院
基础科学部还为培训核心提供资金和基础设施支持。最后,
UTMB教务长的支持信列举了目前和未来对智能交通运输系统的承诺,其中
确保这个监督实体在我们的创新培训计划中取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK R HELLMICH其他文献
MARK R HELLMICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK R HELLMICH', 18)}}的其他基金
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6896603 - 财政年份:2001
- 资助金额:
$ 32.66万 - 项目类别:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6332317 - 财政年份:2001
- 资助金额:
$ 32.66万 - 项目类别:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6752509 - 财政年份:2001
- 资助金额:
$ 32.66万 - 项目类别:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6517796 - 财政年份:2001
- 资助金额:
$ 32.66万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 32.66万 - 项目类别:
Research Grant